Skip to main content
. 2021 Mar 11;14:1107–1115. doi: 10.2147/DMSO.S302761

Table 2.

The General Data of Female T2DM Patients

Variable B1 Group (n=35) B2 Group (n=74) Statistic P
Age(years) 46.8±12.02 45.77±12.98 0.396a 0.693
Course(days) 30.00(15.00,90.00) 30.00(9.75,90.00) −0.224c 0.823
Smoking 2(5.7%) 3(4.1%) 0.000b 1.000
Drinking 4(11.4%) 3(4.1%) 1.098b 0.295
SBP(mmHg) 125.46±12.41 125.24±11.86 0.087a 0.931
DBP(mmHg) 84.11±11.14 82.68±8.79 0.731a 0.467
BMI(kg/m2) 27.45±3.86 25.54±2.62 2.666a 0.010
WC(cm) 90.51±8.86 85.15±4.28 3.399a 0.002
HC(cm) 91.97±6.58 94.51±7.89 1.769a 0.080
WHR(%) 0.96±0.07 0.93±0.06 2.352a 0.021
TC(mmol/l) 5.21±0.91 4.9±1.1 1.462a 0.147
TG(mmol/l) 2.81(1.89,4.65) 1.58(1.02,2.29) −3.651c <0.001
LDL(mmol/l) 3.24±1.19 3.17±0.86 0.300a 0.766
HDL(mmol/l) 0.99±0.17 1.1±0.25 2.398a 0.018
SUA(µmol/L) 307.16±95.15 281.86±70.45 1.558a 0.122
Scr(µmol/L) 59.04±13.06 58.8±13.13 0.091a 0.928
GFR(mL/min) 106.37±10.07 108.5±22.65 0.532a 0.596
FBG(mmol/l) 8.85±1.95 7.61±1.49 3.658a <0.001
FINS(µU/mL) 9.00(4.30,12.60) 6.53(3.78,10.62) −1.233c 0.218
HOMA-IR 3.04(1.49,5.63) 2.00(1.20,3.83) −2.064c 0.039
HbA1c(%) 9.47±1.75 9.28±1.65 0.534a 0.594
LAP 82.80(44.54,118.08) 32.54(23.96,56.46) −4.819c <0.001
VAI 5.09(2.76,6.60) 2.23(1.29,3.30) −4.443c <0.001

Notes: at test; bchi-square test; cMann–Whitney U-test; data were expressed as number (%).

Abbreviations: SBP, systolic blood pressure; DBP, diastolic blood pressure; BMI, body mass index; WC, waist circumference; HC, hip circumference; WHR, waist-to-hip ratio; TC, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein; SUA, serum uric acid; SCr, serum creatinine; GFR, glomerular filtration rate; FBG, fasting blood glucose; FINS, fasting insulin; HOMA-IR, HOMA insulin-resistance; HbA1c, hemoglobin Alc; LAP, lipid accumulation index; VAI, visceral adiposity index.